🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
Androgen deprivation therapy (ADT) by surgical castration or administration...
Status
Unknown
Location
ASZ Aalst
Start Date
2013-04
Trial ID
NCT02440802
Treatments Being Tested
A randomized phase II clinical trial (RADIOSA trial: Radioablation with or ...
Status
Unknown
Location
Istituto Europeo di Oncologia IRCCS
Start Date
2019-10-01
Trial ID
NCT03940235
Treatments Being Tested
This trial is a prospective clinical trial designed to demonstrate the safe...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2023-01-18
Trial ID
NCT05628363
This is a prospective, open-label, multi-center seamless phase II to phase ...
Status
Recruiting
Location
VA Long Beach Healthcare System, Long Beach, CA
Start Date
2021-07-01
Trial ID
NCT04787744
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2011-07
Trial ID
NCT01368588
The objective of this study was to compare the efficacy and safety of the c...
Status
Completed
Location
Site JP00024
Start Date
2016-11-02
Trial ID
NCT02918968
Treatments Being Tested
This phase I trial studies the side effects of cytoreductive prostatectomy ...
Status
Completed
Location
City of Hope National Medical Center (COH)
Start Date
2015-03-06
Trial ID
NCT02458716
This phase II trial tests how well pembrolizumab along with standard of car...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-16
Trial ID
NCT06528210